Allan L. Shaw

Chief Financial Officer at Sirnaomics, Inc.

Allan L. Shaw

Allan L. Shaw

Chief Financial Officer at Sirnaomics, Inc.

Overview
Career Highlights

Sirnaomics, Inc.
Viatel, Inc.
ImmunoMet Therapeutics

RelSci Relationships

971

Number of Boards

8

Birthday

1964

Age

55

Relationships
RelSci Relationships are individuals Allan L. Shaw likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Akari Therapeutics Plc

Relationship likelihood: Strong

Chairman & Chief Executive Officer at Volution Immuno Pharmaceuticals SA

Relationship likelihood: Strong

Former Vice President at The Independent Doctors Federation

Relationship likelihood: Strong

Former Director & Senior Vice President-Corporate Affairs at Smithkline Beecham Ltd.

Relationship likelihood: Strong

Former Managing Partner at Grant Thornton LLP

Relationship likelihood: Strong

Senior Partner at Pearl Cohen Zedek Latzer Baratz LLP

Relationship likelihood: Strong

Chief Executive Officer at The Doctors Laboratory Ltd.

Relationship likelihood: Strong

Chairman of the Board & Chief Executive Officer at Eloxx Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Silence Therapeutics PLC

Relationship likelihood: Strong

Former Chief Executive Officer at Akari Therapeutics Plc

Relationship likelihood: Strong

Paths to Allan L. Shaw
Potential Connections via
Relationship Science
You
Allan L. Shaw
Chief Financial Officer at Sirnaomics, Inc.
Education
Bachelor of Science Degree
Class of 1986

A high quality, respected college on par with a private school (but at the cost of a public school) is what makes SUNY Oswego a great choice for residents of upstate New York and the Northeast in general. Situated alongside a lake in the rural town of Oswego, New York, SUNY Oswego’s environment offers natural beauty and, with its numerous buildings that stretch across hundreds of acres, a spacious campus. At the graduate and undergraduate levels, SUNY Oswego boasts top-notch faculty, a number of whom are Fulbright scholars, published writers and award-winning researchers. In addition to learning from such exceptional faculty, many students also engage in research, another academic advantage of a SUNY Oswego education. Degrees at SUNY Oswego are granted through distinctive schools including the College of Liberal Arts and Sciences, the School of Business, a School of Education and a school for Fine and Performing Arts. Student life is equally impressive, offering over 100 academic, cultural, religious, community service and media-related student organizations. For freshman applicants who have been out of high school for fewer than three years, SAT or ACT scores are required. Additional requirements for all students include a high school diploma or GED as well as transcripts. Tuition is lower for in-state residents and financial aid options are available.

Memberships
Member
Current

The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY.

Member
Current

Founded in 1977, the National Association of Corporate Directors (NACD) is the only national membership organization created by and for directors, providing unparalleled solutions and resources that empower boards to be more effective.The NACD network includes nearly 10,000 directors and executives from leading public, private and nonprofit companies; nationally-recognized firms whose professional services meet important corporate governance needs; and governance experts from academia and elsewhere.

Member
Current

The New York State Society of Certified Public Accountants (NYSSCPA) is one of the largest state accounting organizations in the nation with more than 28,000 members. It was incorporated in 1897 to cultivate, promote, and disseminate knowledge and information concerning certified public accountants;to establish and maintain high standards of integrity, honor, and character among certified public accountants;to furnish information regarding accountancy and the practice and methods thereof to its members and the general public;to protect the interests of its members and the general public with respect to the practice of accountancy.

Career History
Chief Financial Officer
Prior

Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland.

Founder
2005 - 2009

Strategic Capital is a unique real estate investment firm that originates and provides funding for both income and non-income properties.

Executive Director
2009 - 2011

NewLead Holdings Ltd. is a shipping, logistics, and commodity company, which engages in the seaborne transportation of petroleum products and dry bulk commodities. It operates through the Wet and Dry Operations segments. The Wet Operations segment deals with the transportation of asphalt through ownership, operation, and management of vessels. The Dry Operations segment consists of the transportation and handling of bulk cargoes. The company was founded on January 12, 2005 and is headquartered in Piraeus, Greece.

Boards & Committees
Member, Board of Directors
Current
Independent Director
2015 - 2019

VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm's products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and is headquartered in Campbell, CA.

Independent Director
2013 - 2016

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in London, the United Kingdom.

Director
Current

Since 1927, the Marks JCH has been the hub of activity for millions of people. Throughout the year, programs and services are offered for young and old alike. Each week, thousands of people of all ages and backgrounds crowd the corridors of the place on Bay Parkway lovingly known as the "J."

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Allan L. Shaw. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Allan L. Shaw's profile does not indicate a business or promotional relationship of any kind between RelSci and Allan L. Shaw.